Skip to main content
Download PDF

Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Breast Cancer Research volume 26, Article number: 53 (2024) Cite this article

The Original Article was published on 05 February 2024

Qian et al. Breast Cancer Research (2024) 26:23

https://doi.org/10.1186/s13058-024-01778-w

The original article has incomplete funding information with regard to author Negar Koupaei. The complete funding note is as follows:

Funding

This work was funded by a Susan G Komen Promise Grant (KG081694 P.H.B.), a Komen SAB Grant (9SAB12-00006, P.H.B.), and a CCSG Grant (P30 CA016672, P.H.B.). This work was also supported by the John Charles Cain Endowment (P.H.B.). Negar Koupaei (NK) was supported by the 1R25CA240137-01A1 UPWARDS Training Program and by the CPRIT Research Training Award CPRIT Training Program (RP210028).

The original article [1] has been corrected.

References

  1. Qian J, Ma Y, Tahaney WM, et al. The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth. Breast Cancer Res. 2024;26:23. https://doi.org/10.1186/s13058-024-01778-w.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Jing Qian, Yanxia Ma, William M. Tahaney, Cassandra L. Moyer, Amanda Lanier, Jamal Hill, Darian Coleman, Negar Koupaei, Michelle I. Savage, Abhijit Mazumdar & Powel H. Brown

  2. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA

    William M. Tahaney & Powel H. Brown

  3. Lester and Sue Smith Breast Center and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA

    Susan G. Hilsenbeck

  4. Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Negar Koupaei

  5. Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada

    Brent D. G. Page

  6. Monte Rosa Therapeutics, Boston, USA

    William M. Tahaney

  7. Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Yanxia Ma

  8. The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA

    Jing Qian

Authors
  1. Jing Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yanxia Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William M. Tahaney
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cassandra L. Moyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Amanda Lanier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jamal Hill
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Darian Coleman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Negar Koupaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Susan G. Hilsenbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Michelle I. Savage
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Brent D. G. Page
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Abhijit Mazumdar
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Powel H. Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Powel H. Brown.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s13058-024-01778-w.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qian, J., Ma, Y., Tahaney, W.M. et al. Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth. Breast Cancer Res 26, 53 (2024). https://doi.org/10.1186/s13058-024-01814-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13058-024-01814-9

Breast Cancer Research

ISSN: 1465-542X

Contact us